Absorption Models to Examine Bioavailability and Drug-Drug Interactions in Humans

被引:0
|
作者
Rizwan, Ahsan Naqi [1 ]
Brouwer, Kim L. R. [1 ]
机构
[1] Univ N Carolina, Eschelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA
关键词
DIFFERENT REGIONS; IN-VITRO; JEJUNAL PERMEABILITY; BILIARY-EXCRETION; SMALL-INTESTINE; GI TRACT; PERFUSION; METABOLISM; PHARMACOKINETICS; EXPERIENCE;
D O I
10.1007/978-1-4419-0840-7_14
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human drug absorption studies are warranted in many situations. The development of modified release formulations, the evaluation of different formulations designed to improve bioavailability by enhancing solubility or permeability, the investigation of mechanisms of drug-drug/food interactions in the gastrointestinal tract, and the determination of intestinal and biliary secretion in humans all require assessment of drug absorption/excretion in the human gastrointestinal tract. This chapter discusses in vivo approaches that can be used to assess absorption/bioavailability issues in the human gastrointestinal tract. The design and the application of remotely activated capsules and aspiration/perfusion catheters are reviewed, and the utility of human microdose studies is discussed. With the use of appropriate probes, these approaches also may be used to assess drug drug or drug food interactions, as well as interactions involving transporters and enzymes present in the gastrointestinal tract and/or the liver.
引用
收藏
页码:343 / 370
页数:28
相关论文
共 50 条
  • [1] Evaluation of desloratadine for absorption drug-drug interactions with ketoconazole
    Hwang, KK
    Correll, M
    Offord, SJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S153 - S153
  • [2] DRUG-DRUG INTERACTIONS
    FORTH, W
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [3] Drug-drug interactions
    Preskorn, SH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [4] Bioavailability Considerations in Evaluating Drug-Drug Interactions Using the Population Pharmacokinetic Approach
    Duan, John Z.
    Jackson, Andre J.
    Zhao, Ping
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (07): : 1087 - 1100
  • [5] Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions
    Eisenmann, Eric D.
    Talebi, Zahra
    Sparreboom, Alex
    Baker, Sharyn D.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 23 - 35
  • [6] Web-Based Database as a Tool to Examine Drug-Drug Interactions Involving Transporters
    Maeda, Kazuya
    Shitara, Yoshihasa
    Horie, Toshiharu
    Sugiyama, Yuichi
    [J]. ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 387 - 412
  • [7] Evaluation of models for predicting drug-drug interactions due to induction
    Fahmi, Odette A.
    Ripp, Sharon L.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1399 - 1416
  • [8] Conceptual models of drug-drug interactions: A summary of recent efforts
    Herrero-Zazo, Maria
    Segura-Bedmar, Isabel
    Martinez, Paloma
    [J]. KNOWLEDGE-BASED SYSTEMS, 2016, 114 : 99 - 107
  • [9] Drug-drug interactions in man:: predictive value of in vitro models
    Weber, F
    Becquemont, L
    [J]. THERAPIE, 2000, 55 (04): : 569 - 575
  • [10] Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions
    Cami, Aurel
    Manzi, Shannon
    Arnold, Alana
    Reis, Ben Y.
    [J]. PLOS ONE, 2013, 8 (04):